Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case–control study
2006

Study of PADI4 Variability in German Rheumatoid Arthritis Patients

Sample size: 204 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hoppe Berthold, Häupl Thomas, Gruber Rudolf, Kiesewetter Holger, Burmester Gerd R, Salama Abdulgabar, Dörner Thomas

Primary Institution: Charité-Universitätsmedizin Berlin, Germany

Hypothesis

Variability of the PADI4 gene may influence susceptibility to rheumatoid arthritis in the German population.

Conclusion

The study found a significant association between PADI4 haplotype 4 and rheumatoid arthritis in German patients, but no influence on disease activity or anti-CCP levels.

Supporting Evidence

  • PADI4 haplotype 4 was found in 14.7% of RA patients compared to 7.8% of controls.
  • The presence of the HLA-DRB1 shared epitope was significantly associated with higher anti-CCP levels.
  • Three SNPs (padi4_89, padi4_90, padi4_94) were significantly associated with RA.

Takeaway

This study looked at a gene called PADI4 to see if it makes people more likely to get rheumatoid arthritis. They found that one version of this gene is more common in people with the disease.

Methodology

The study analyzed exons 2–4 of PADI4 in 102 RA patients and 102 healthy controls using haplotype-specific DNA sequencing.

Potential Biases

Potential selection bias due to the homogeneous Caucasian population.

Limitations

The study's sample size was relatively small, which may limit the generalizability of the findings.

Participant Demographics

102 RA patients (median age 47 years, 75% women) and 102 healthy controls (median age 40 years, 57% women).

Statistical Information

P-Value

0.04

Confidence Interval

1.1–3.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar1889

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication